65841-260 : Ribavirin 200 mg Oral Capsule


NDC: 65841-260
Labeler: Cadila Healthcare Limited
Product Type: Human Prescription Drug
Drug Name:  Ribavirin
Dosage Form: Oral Capsule
Application #: ANDA077224
Rev. Date: 


Appearance:


Markings: ZA;12;200mg
Shapes:  Capsule
Colors:  White
Size (mm): 22
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 65841-260-03: 168 CAPSULE IN 1 BOTTLE (65841‑260‑03)
  • 65841-260-04: 42 CAPSULE IN 1 BOTTLE (65841‑260‑04)
  • 65841-260-07: 56 CAPSULE IN 1 BOTTLE (65841‑260‑07)
  • 65841-260-09: 70 CAPSULE IN 1 BOTTLE (65841‑260‑09)
  • 65841-260-10: 1000 CAPSULE IN 1 BOTTLE (65841‑260‑10)
  • 65841-260-12: 84 CAPSULE IN 1 BOTTLE (65841‑260‑12)
  • 65841-260-13: 140 CAPSULE IN 1 BOTTLE (65841‑260‑13)
  • 65841-260-28: 180 CAPSULE IN 1 BOTTLE (65841‑260‑28)
  • 65841-260-30: 10 BLISTER PACK IN 1 CARTON (65841‑260‑30) > 10 CAPSULE IN 1 BLISTER PACK

Active Ingredients:

  • Ribavirin

Dosage Strength:

  • 200 mg

Inactive Ingredients:

  • Crospovidone
  • Magnesium Stearate
  • Gelatin
  • Povidone
  • Titanium Dioxide
  • Silicon Dioxide
  • Cellulose, Microcrystalline

Pharmaceutical Classes:

  • Nucleoside Analog [Chemical/Ingredient]
  • Nucleoside Analog Antiviral [EPC]

Related Products:

Based on records with the same trade name.
  • 65841-046 Ribavirin 200 mg Oral Tablet by Cadila Healthcare Limited
  • 65841-129 Ribavirin 600 mg Oral Tablet by Cadila Healthcare Limited
  • 65841-603 Ribavirin 400 mg Oral Tablet by Cadila Healthcare Limited
  • 65841-632 Ribavirin 500 mg Oral Tablet by Cadila Healthcare Limited
  • 0093-7227 Ribavirin 200 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7232 Ribavirin 200 mg Oral Tablet by Teva Pharmaceuticals USA Inc
  • 0781-2043 Ribavirin 200 mg Oral Capsule by Sandoz Inc
  • 0781-5177 Ribavirin 200 mg Oral Tablet by Sandoz Inc
  • 42291-718 Ribavirin 200 mg/1 Oral Capsule by Avkare, Inc.
  • 42494-423 Ribavirin 6 g/1 Respiratory (Inhalation) Powder, for Solution by Cameron Pharmaceuticals
  • 53808-0781 Ribavirin 200 mg Oral Capsule by State of Florida Doh Central Pharmacy
  • 53808-0782 Ribavirin 200 mg Oral Tablet by State of Florida Doh Central Pharmacy
  • 54738-950 Ribavirin 200 mg Oral Tablet by Richmond Pharmaceuticals, Inc.
  • 54738-951 Ribavirin 400 mg Oral Tablet by Richmond Pharmaceuticals, Inc.
  • 54738-952 Ribavirin 600 mg Oral Tablet by Richmond Pharmaceuticals, Inc.
  • 54738-953 Ribavirin 200 mg Oral Capsule by Richmond Pharmaceuticals, Inc.
  • 63629-2149 Ribavirin 6 g/1 Respiratory (Inhalation) Powder, for Solution by Bryant Ranch Prepack
  • 65862-207 Ribavirin 200 mg Oral Tablet by Aurobindo Pharma Limited
  • 65862-290 Ribavirin 200 mg Oral Capsule by Aurobindo Pharma Limited
  • 68084-150 Ribavirin 200 mg Oral Tablet by American Health Packaging
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 65841-260 QR Code

< Prev: 65841-129Next: 65841-536 >

Related Discussions:

Ribavirin-Interferon long term side effects
Hi. I was treated for chronic Hep C 20 years ago and been having continuous health problems arise over past 5 years. I w... 3 replies
Ribavirin reaction
I took peginterferon shots once a week with 6 ribavirin tablets a day. I had skin reactions and scatched all the hair of... 3 replies
sovaldi and ribavirin
66 years old, geno 2, 24 mo treatment, just finished treatment jan.5, 2015, now feb 8, still have headaches, itching, an... 4 replies
drug interaction with sovaldi and ribavirin
can you take lithium while taking sovaldi and ribavirin ## Hello, Polly! How are you? I didn't find any interactions... 2 replies
Pegasys AND RIBAVIRIN AE NUMBERS
Dear sir; requesting your kind assistance to provide me with the AMERICAN EQUIVALENT DRUG NUMBER (AE) of:- 1- Pegasys in...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.